|
|
Pra Health Sciences Inc (PRAH) |
|
|
|
Pra Health Sciences Inc 's Yearly Free Cash Flow Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Free Cash Flow Annual Growth Rates Y/Y▼
|
Annual Free Cash Flow Annual Growth Rates Y/Y▼
|
PRAH Annual Free Cash Flow Growth |
2020
|
2019
|
2018
|
2017
|
2016
|
Y / Y Annual Free Cash Flow Change |
101.01 % |
-34.55 % |
72.14 % |
- |
- |
Annual Free Cash Flow (in millions $) |
$360.40 |
$179.30 |
$273.96 |
$159.15 |
$0.00 |
Annual Free Cash Flow Growth
Comment |
Pra Health Sciences Inc 's Annual Free Cash Flow for the fiscal year ended 2020, more than doubled to 101.01% to $360.40 millions, from $179.30 millions achieved a year ago. Pra Health Sciences Inc 's growrh rate for Free Cash Flow improved from -34.55 % decline in the fiscal year 2019.
Pra Health Sciences Inc Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2020 Annual Free Cash Flow within Healthcare Sector | Y/Y Free Cash Flow Growth % | 2020 Annual Free Cash Flow | Becton Dickinson And Company | 15.00 % | $ 2,729.000 millions | Regeneron Pharmaceuticals Inc | 0.15 % | $ 2,003.500 millions | Alexion Pharmaceuticals Inc | 51.30 % | $ 2,896.200 millions | Stryker Corp | 80.93 % | $ 2,790.000 millions | Vertex Pharmaceuticals Inc | 100.40 % | $ 2,993.707 millions | Zoetis Inc | 24.93 % | $ 1,694.000 millions | Davita Inc | -0.10 % | $ 1,304.487 millions | Bausch Health Companies Inc | -34.42 % | $ 802.000 millions | Zimmer Biomet Holdings Inc | -8.00 % | $ 1,086.600 millions | Intuitive Surgical Inc | -2.50 % | $ 1,143.300 millions | Laboratory Corporation Of America Holdings | 70.66 % | $ 1,795.700 millions | Quest Diagnostics Inc | 70.24 % | $ 1,590.000 millions | Edwards Lifesciences Corporation | -28.19 % | $ 647.000 millions | Agilent Technologies inc | -7.17 % | $ 803.000 millions | Illumina Inc | 5.82 % | $ 891.000 millions | Iqvia Holdings Inc | 60.84 % | $ 1,343.000 millions | Universal Health Services Inc | 102.50 % | $ 1,628.862 millions | Ligand Pharmaceuticals Incorporated | -93.58 % | $ 50.128 millions | Jazz Pharmaceuticals Plc | 17.30 % | $ 785.903 millions | Xbiotech Inc | | | |